Walleye Capital’s Repare Therapeutics RPTX Stock Holding History

Walleye Capital’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-106,683	Closed	-$277K	–	4909
2025 Q4	$277K	Buy	+106,683	New	+$215K	﹤0.01%	3364
2021 Q2	–	Sell	-8,310	Closed	-$255	–	1487
2021 Q1	$255	Buy	+8,310	New	+$282K	0.01%	831

Walleye Capital's RPTX Position: Q1 2026 in Review

Walleye Capital sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 106,683 shares — an estimated $277K sold.

Walleye Capital first reported a position in RPTX in Q1 2021 and held it in 2 quarters. The position peaked at $277K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Walleye Capital reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 106,683 Repare Therapeutics shares in Q1 2026, an estimated $277K.
Walleye Capital first reported a position in Repare Therapeutics in Q1 2021 and held it in 2 quarters.
Walleye Capital's Repare Therapeutics position peaked at $277K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.